Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Mid-Size Pharmaceuticals Market Growth in 2025?
The market size of mid-size pharmaceutical companies has been displaying strong growth in previous years, transitioning from $718.71 billion in 2024 to a projected $768.01 billion in 2025 with a compound annual growth rate (CAGR) of 6.9%. Factors propelling growth during the historic period include the expansion of the generic drug market, the expiry of patents of popular drugs, measures taken to contain healthcare costs, biotechnology advancements, and regulatory shifts that promote innovation.
What Is the Forecast for the Mid-Size Pharmaceuticals Market Size Through 2029?
Expectations are high for robust expansion in the mid-size pharmaceuticals market in the upcoming years. The projection stands at $1002.26 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. Various factors will contribute to the growth in this period, including a shift towards value-based care models, streamlined regulatory pathways, heightened health consciousness and patient autonomy, demand for generic and biosimilar medicines, and the rise of digital therapeutics. Major forecasted trends encompass a greater emphasis on patient-oriented methods, integration of artificial intelligence (AI), global market reach tactics, environmental sustainability measures, telemedicine, and remote patient supervision.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12045&type=smp
What are the Key Market Players in Mid-Size Pharmaceuticals Market and How They’re Evolving?
Major companies operating in the mid-size pharmaceuticals market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.
What Are the Primary Growth Drivers in the Mid-Size Pharmaceuticals Market?
The escalating occurrence of long-term medical conditions, also referred to as non-communicable diseases or chronic diseases, is predicted to drive the expansion of the mid-size pharmaceuticals market. These chronic conditions demand continual treatment and medication, thereby fostering a high demand for drugs. Techniques such as mass spectrometry are employed to identify, quantify and analyze biomarkers and metabolites linked to these chronic illnesses. This surge in chronic disease prevalence is expected to stimulate the growth of the mid-sized pharmaceuticals market. In September 2023, the World Health Organization, an agency specialized in health matters within the United Nations based in Switzerland reported 41 million deaths, accounting for 74% of those triggered by non-communicable or chronic diseases globally each year. Consequently, this uptick in chronic disease occurrence is spearheading the growth of the mid-size pharmaceuticals market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12045&type=smp
What Are the Leading Segments in the Global Mid-Size Pharmaceuticals Industry?
The mid-size pharmaceuticals market covered in this report is segmented –
1) By Drug Development Type: In-House, Outsource
2) By Type: Prescription, Over The Counter
3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations
4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions
Subsegments:
1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management
2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)
What Are the Key Market Trends in the Mid-Size Pharmaceuticals Industry?
The rapid progression of technology is a notable trend in the mid-size pharmaceuticals market that is garnering significant attention. Major players in the mid-size pharmaceuticals market leverage technology to maintain their market standing. For example, Google Cloud, a product of US-based Google that provides a suite of cloud computing services, launched AI-based tools in May 2023. These tools, developed to expedite drug discovery and precision medicine, include the Target and Lead Identification Suite, which helps businesses predict and understand protein structures, an integral part of drug research. The Multiomics Suite is another such tool that aids researchers in the input, storage, analysis, and sharing of large amounts of genetic data.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/mid-size-pharmaceuticals-global-market-report
What Is the Regional Outlook for the Mid-Size Pharmaceuticals Market?
North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mid-size pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12045
This Report Delivers Insight On:
1. How big is the mid-size pharmaceuticals market, and how is it changing globally?
2. Who are the major companies in the mid-size pharmaceuticals market, and how are they performing?
3. What are the key opportunities and risks in the mid-size pharmaceuticals market right now?
4. Which products or customer segments are growing the most in the mid-size pharmaceuticals market?
5. What factors are helping or slowing down the growth of the mid-size pharmaceuticals market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
